{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T21:55:07Z","timestamp":1788990907686,"version":"build-2803163510"},"reference-count":52,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"British Columbia Centre for Disease Control"},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"name":"NHC","award":["142832"],"award-info":[{"award-number":["142832"]}]},{"name":"NHC","award":["PHE-141773"],"award-info":[{"award-number":["PHE-141773"]}]},{"DOI":"10.13039\/501100000245","name":"British Columbia Michael Smith Foundation for Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000245","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Canadian Network on Hepatitis C"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-hepatology.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.jhep.2019.07.021","type":"journal-article","created":{"date-parts":[[2019,8,6]],"date-time":"2019-08-06T19:41:24Z","timestamp":1565120484000},"page":"1116-1125","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Sustained virological response from interferon-based hepatitis C regimens is associated with reduced risk of extrahepatic manifestations"],"prefix":"10.1016","volume":"71","author":[{"given":"Carmine","family":"Rossi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dahn","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanley","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey","family":"McKee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahid Ahmad","family":"Butt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Buxton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Darvishian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Bartlett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasina","family":"Samji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mawuena","family":"Binka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Alvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prince Asumadu","family":"Adu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Tyndall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mel","family":"Krajden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naveed Zafar","family":"Janjua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2019.07.021_b0005","first-page":"161","article-title":"Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study","volume":"2","year":"2017","journal-title":"LancetGastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2019.07.021_b0010","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1053\/j.gastro.2015.08.035","article-title":"Extrahepatic morbidity and mortality of chronic hepatitis C","volume":"149","author":"Negro","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2019.07.021_b0015","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1053\/j.gastro.2016.02.039","article-title":"Extrahepatic manifestations of hepatitis C: A meta-analysis of prevalence, quality of life, and economic burden","volume":"150","author":"Younossi","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2019.07.021_b0020","first-page":"3","article-title":"Extrahepatic manifestations of chronic hepatitis C virus infection","volume":"3","author":"Cacoub","year":"2016","journal-title":"Ther Adv Infect Dis"},{"key":"10.1016\/j.jhep.2019.07.021_b0025","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1111\/apt.12234","article-title":"Associations of chronic hepatitis C with metabolic and cardiac outcomes","volume":"37","author":"Younossi","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2019.07.021_b0030","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2015.09.007","article-title":"Hepatitis C virus infection is associated with increased cardiovascular mortality: a meta-analysis of observational studies","volume":"150","author":"Petta","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2019.07.021_b0035","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/hep.29505","article-title":"Chronic hepatitis C virus (HCV) increases the risk of chronic kidney disease (CKD) while effective HCV treatment decreases the incidence of CKD","volume":"67","author":"Park","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2019.07.021_b0040","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.ahj.2017.10.024","article-title":"Prognostic value of viral eradication for major adverse cardiovascular events in hepatitis C cirrhotic patients","volume":"198","author":"Cacoub","year":"2018","journal-title":"Am Heart J"},{"key":"10.1016\/j.jhep.2019.07.021_b0045","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/nrgastro.2017.172","article-title":"Extrahepatic cancers and chronic HCV infection","volume":"15","author":"Pol","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2019.07.021_b0050","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/liv.13272","article-title":"The impact of hepatitis C virus outside the liver: evidence from Asia","volume":"37","author":"Younossi","year":"2017","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2019.07.021_b0055","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1111\/jvh.12881","article-title":"Direct medical costs associated with the extrahepatic manifestations of hepatitis C infection in Europe","volume":"25","author":"Cacoub","year":"2018","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.jhep.2019.07.021_b0060","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1111\/jvh.12414","article-title":"Increase in nonhepatic diagnoses among persons with hepatitis C hospitalized for any cause, United States, 2004\u20132011","volume":"22","author":"Tong","year":"2015","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.jhep.2019.07.021_b0065","doi-asserted-by":"crossref","first-page":"ofw173","DOI":"10.1093\/ofid\/ofw173","article-title":"Patterns of healthcare utilization among veterans infected with hepatitis C virus (HCV) and human immunodeficiency virus (HIV) and coinfected with HIV\/HCV: unique burdens of disease","volume":"3","author":"Katrak","year":"2016","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.jhep.2019.07.021_b0070","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1093\/cid\/civ396","article-title":"Long-term treatment outcomes of patients infected with hepatitis C virus: a systematic review and meta-analysis of the survival benefit of achieving a sustained virological response","volume":"61","author":"Simmons","year":"2015","journal-title":"Clinical Infect Dis"},{"key":"10.1016\/j.jhep.2019.07.021_b0075","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1136\/gutjnl-2018-316234","article-title":"Impact of sustained virological response on the extrahepatic manifestations of chronic hepatitis C: a meta-analysis","volume":"67","author":"Cacoub","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2019.07.021_b0080","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1002\/hep.22703","article-title":"Sustained virological response reduces incidence of onset of type 2 diabetes in chronic hepatitis C","volume":"49","author":"Arase","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2019.07.021_b0085","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/jmv.23777","article-title":"Impact of virus clearance for the development of hemorrhagic stroke in chronic hepatitis C","volume":"86","author":"Arase","year":"2014","journal-title":"J Med Virol"},{"key":"10.1016\/j.jhep.2019.07.021_b0090","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1136\/gutjnl-2014-308163","article-title":"Association between antiviral treatment and extrahepatic outcomes in patients with hepatitis C virus infection","volume":"64","author":"Hsu","year":"2015","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2019.07.021_b0095","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1111\/j.1872-034X.2011.00845.x","article-title":"Development rate of chronic kidney disease in hepatitis C virus patients with advanced fibrosis after interferon therapy","volume":"41","author":"Arase","year":"2011","journal-title":"Hepatol Res"},{"key":"10.1016\/j.jhep.2019.07.021_b0100","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/nrgastro.2016.176","article-title":"Global epidemiology and burden of HCV infection and HCV-related disease","volume":"14","author":"Thrift","year":"2017","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2019.07.021_b0105","article-title":"Hepatitis C virus treatment with directly acting agents reduces the risk of incident diabetes \u2013 results from ERCHIVES","author":"Butt","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jhep.2019.07.021_b0110","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2018.11.022","article-title":"Direct-acting antiviral therapy for HCV infection is associated with a reduced risk of cardiovascular disease events","volume":"156","author":"Butt","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2019.07.021_b0115","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1111\/apt.15240","article-title":"The effects of sustained virological response to direct-acting anti-viral therapy on the risk of extrahepatic manifestations of hepatitis C infection","volume":"49","author":"El-Serag","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2019.07.021_b0120","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1111\/jvh.12887","article-title":"Impact of sustained virologic response on risk of type 2 diabetes among hepatitis C patients in the United States","volume":"25","author":"Li","year":"2018","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.jhep.2019.07.021_b0125","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1136\/gutjnl-2017-313983","article-title":"The effect of sustained virological response on the risk of extrahepatic manifestations of hepatitis C virus infection","volume":"67","author":"Mahale","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2019.07.021_b0130","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/hep.29071","article-title":"Eradication of hepatitis C virus and non-liver-related non-acquired immune deficiency syndrome-related events in human immunodeficiency virus\/hepatitis C virus coinfection","volume":"66","author":"Berenguer","year":"2017","journal-title":"Hepatology"},{"issue":"142\u2013156","key":"10.1016\/j.jhep.2019.07.021_b0135","article-title":"Eradication of hepatitis C virus infection in patients with cirrhosis reduces risk of liver and non-liver complications","volume":"152","author":"Nahon","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2019.07.021_b0140","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1136\/gutjnl-2018-316578","article-title":"Expanded benefits of curing the extrahepatic manifestations of HCV infection","volume":"67","author":"Negro","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2019.07.021_b0145","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0150176","article-title":"Assessing hepatitis C burden and treatment effectiveness through the british columbia hepatitis testers cohort (BC-HTC): design and characteristics of linked and unlinked participants","volume":"11","author":"Janjua","year":"2016","journal-title":"PloS One"},{"key":"10.1016\/j.jhep.2019.07.021_b0150","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.jhep.2016.10.028","article-title":"Long-term effect of sustained virological response on hepatocellular carcinoma in patients with hepatitis C in Canada","volume":"66","author":"Janjua","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2019.07.021_b0155","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1214\/aos\/1176350951","article-title":"A class of K-sample tests for comparing the cumulative incidence of a competing risk","volume":"16","author":"Gray","year":"1988","journal-title":"Ann Stat"},{"key":"10.1016\/j.jhep.2019.07.021_b0160","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1093\/biomet\/81.3.515","article-title":"Proportional hazards tests and diagnostics based on weighted residuals","volume":"81","author":"Grambsch","year":"1994","journal-title":"Biometrika"},{"key":"10.1016\/j.jhep.2019.07.021_b0165","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1093\/infdis\/jis385","article-title":"Chronic hepatitis C virus infection increases mortality from hepatic and extrahepatic diseases: a community-based long-term prospective study","volume":"206","author":"Lee","year":"2012","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jhep.2019.07.021_b0170","doi-asserted-by":"crossref","first-page":"S95","DOI":"10.1016\/j.jhep.2016.07.039","article-title":"Reversion of disease manifestations after HCV eradication","volume":"65","author":"van der Meer","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2019.07.021_b0175","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.jhep.2008.08.006","article-title":"Hepatitis C infection and risk of diabetes: a systematic review and meta-analysis","volume":"49","author":"White","year":"2008","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2019.07.021_b0180","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/liv.13194","article-title":"Chronic hepatitis C virus infection and the risk for diabetes: a community-based prospective study","volume":"37","author":"Lin","year":"2017","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2019.07.021_b0185","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1002\/hep.27047","article-title":"Relationship of hepatitis C virus infection with diabetes in the U.S. population","volume":"60","author":"Ruhl","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2019.07.021_b0190","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jare.2016.11.003","article-title":"Current level of evidence on causal association between hepatitis C virus and type 2 diabetes: a review","volume":"8","author":"Gastaldi","year":"2017","journal-title":"J Adv Res"},{"key":"10.1016\/j.jhep.2019.07.021_b0195","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.cgh.2018.05.021","article-title":"Long-term efficacy of interferon-free antiviral treatment regimens in patients with hepatitis C virus-associated cryoglobulinemia vasculitis","volume":"17","author":"Cacoub","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2019.07.021_b0200","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1093\/ndt\/gfr236","article-title":"Effect of interferon-alpha-based antiviral therapy on hepatitis C virus-associated glomerulonephritis: a meta-analysis","volume":"27","author":"Feng","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jhep.2019.07.021_b0205","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1002\/hep.26892","article-title":"Antiviral treatment for hepatitis C virus infection is associated with improved renal and cardiovascular outcomes in diabetic patients","volume":"59","author":"Hsu","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2019.07.021_b0210","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1161\/STROKEAHA.110.598136","article-title":"Hepatitis C virus infection and increased risk of cerebrovascular disease","volume":"41","author":"Lee","year":"2010","journal-title":"Stroke"},{"key":"10.1016\/j.jhep.2019.07.021_b0215","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.25508","article-title":"Carotid atherosclerosis and chronic hepatitis C: a prospective study of risk associations","volume":"55","author":"Petta","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2019.07.021_b0220","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.atherosclerosis.2012.01.051","article-title":"Chronic HCV infection is a risk of atherosclerosis. Role of HCV and HCV-related steatosis","volume":"221","author":"Adinolfi","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jhep.2019.07.021_b0225","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jhep.2018.02.015","article-title":"Hepatitis C virus eradication by direct-acting antiviral agents improves carotid atherosclerosis in patients with severe liver fibrosis","volume":"69","author":"Petta","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2019.07.021_b0230","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/apt.12391","article-title":"Interferon-based therapy reduces risk of stroke in chronic hepatitis C patients: a population-based cohort study in Taiwan","volume":"38","author":"Hsu","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2019.07.021_b0235","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1186\/s12879-016-1683-z","article-title":"Twin epidemics of new and prevalent hepatitis C infections in Canada: BC Hepatitis Testers Cohort","volume":"16","author":"Janjua","year":"2016","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jhep.2019.07.021_b0240","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0183609","article-title":"A syndemic approach to assess the effect of substance use and social disparities on the evolution of HIV\/HCV infections in British Columbia","volume":"12","author":"Butt","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jhep.2019.07.021_b0245","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.eclinm.2018.10.006","article-title":"Syndemic characterization of HCV, HBV, and HIV co-infections in a large population based Cohort study","volume":"4\u20135","author":"McKee","year":"2018","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.jhep.2019.07.021_b0250","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.2147\/CLEP.S173449","article-title":"Effect of opioid-substitution therapy and mental health counseling on HIV risk among hepatitis C-infected individuals","volume":"10","author":"Butt","year":"2018","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.jhep.2019.07.021_b0255","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/hep.26229","article-title":"Improvement of neurocognitive function in responders to an antiviral therapy for chronic hepatitis C","volume":"58","author":"Kraus","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2019.07.021_b0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2016.10.037","article-title":"Sofosbuvir and velpatasvir combination improves patient-reported outcomes for patients with HCV infection, without or with compensated or decompensated cirrhosis","volume":"15","author":"Younossi","year":"2017","journal-title":"Clin Gastroenterol Hepatol"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827819304623?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827819304623?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T19:37:30Z","timestamp":1759174650000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827819304623"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":52,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["S0168827819304623"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2019.07.021","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sustained virological response from interferon-based hepatitis C regimens is associated with reduced risk of extrahepatic manifestations","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2019.07.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}